Prudential Financial
ALDX icon

Prudential Financial’s Aldeyra Therapeutics ALDX Stock Holding History

Prudential Financial’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-39,654
Closed -$176K – 2659
2022
Q1 		$176K Buy
+39,654
New +$158K ﹤0.01% 2520

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Prudential Financial's ALDX Position: Q2 2022 in Review

Prudential Financial sold out of Aldeyra Therapeutics (ALDX) in Q2 2022, closing a stake of 39,654 shares — an estimated $176K sold.

Prudential Financial first reported a position in ALDX in Q1 2022 and held it in 1 quarter. The position peaked at $176K in Q1 2022. 95 funds tracked by Wall St. Rank hold ALDX as of Q2 2022.

  • Prudential Financial reported no remaining Aldeyra Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Prudential Financial sold 39,654 Aldeyra Therapeutics shares in Q2 2022, an estimated $176K.
  • Prudential Financial first reported a position in Aldeyra Therapeutics in Q1 2022 and held it in 1 quarter.
  • Prudential Financial's Aldeyra Therapeutics position peaked at $176K in Q1 2022.
  • 95 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2022.

Based on Prudential Financial's 13F filing for Q2 2022, filed 15 Aug 2022.